MedTrace Logo

Usefulness of Alpha-GST in Liver Transplantation

NCT02451046 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2015-05-21

No results posted yet for this study

Summary

The primary objective of this study was to evaluate the ability of plasma alpha-GST measurements in liver donor (at the time of organ removal) to predict primary dysfunction in liver recipient. The secondary objective was to study the relationship between alpha-GST levels in the plasma of the liver transplant recipient and early graft function recovery.

Conditions

  • Evidence of Liver Transplantation

Sponsors & Collaborators

  • Beaujon Hospital

    lead OTHER

Principal Investigators

  • Catherine Paugam-Burtz, MD-PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02451046 on ClinicalTrials.gov